semaglutide news today 2025 Novo Nordisk has announced that the FDA has approved the Wegovy® pill (once-daily oral 25 mg) as the first ever oral GLP-1 receptor agonist therapy for chronic weight management in adults Semaglutide generic: What you need

Refrigeration requirements vary by compound

Tracking these changes can help you adapt your eating habits for maximum benefit

Recent reviews suggest GLP-1 receptor agonists may support ovulatory frequency in some women by addressing underlying metabolic dysfunction, though larger long-term fertility trials are still needed

Upper arm: The back of the upper arm

Gastrointestinal adverse effects are the most common side effects of semaglutide, with rates varying by product and dose

However, if you were on high-dose tirzepatide and switch to semaglutide, the reduced overall potency may result in somewhat less weight suppression long-term